Cleared Traditional

K161970 - Follicle Aspiration Set

K161970 is an FDA 510(k) clearance for Follicle Aspiration Set, manufactured by Vitrolife Sweden AB. The device is a Class 2 Obstetrics & Gynecology device with product code MQE cleared through the Traditional 510(k) pathway after a 331-day FDA review.

K161970 · Vitrolife Sweden AB · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
331d
Days
Class 2
Risk

K161970 is an FDA 510(k) clearance for the Follicle Aspiration Set. Classified as Needle, Assisted Reproduction (product code MQE), Class II - Special Controls.

Submitted by Vitrolife Sweden AB (Västra Frölunda, SE). The FDA issued a Cleared decision on June 14, 2017 after a review of 331 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6100 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vitrolife Sweden AB devices

FDA 510(k) Submission Details - K161970

510(k) Number K161970 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2016
Decision Date June 14, 2017
Days to Decision 331 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
171d slower than avg
Panel avg: 160d · This submission: 331d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQE Device Classification - Class 2, Special Controls

Product Code MQE Needle, Assisted Reproduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Regulatory Specialists, Inc.
GREG HOLLAND

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQE Needle, Assisted Reproduction

All 26
Devices cleared under the same product code (MQE) and FDA review panel - the closest regulatory comparables to K161970.
Double Lumen Ovum Aspiration Needles
K171611 · William A. Cook Australia Pty. , Ltd. · Dec 2017
Follicle Aspiration Set, Reduced Single Lumen
K172050 · Vitrolife Sweden AB · Nov 2017
Kitazato OPU Needles
K162881 · Kitazato Corporation · Jul 2017
OTRIEVA TAPERED OVUM ASPIRATION NEEDLE SINGLE LUMEN
K141365 · William A. Cook Australia Pty. , Ltd. · Aug 2014
KITAZATO OPU NEEDLE
K112462 · Kitazato Medical Co., Ltd. · Nov 2012
FOLLICLE ASPIRATION SET, REDUCED SINGLE LUMEN
K082727 · Vitrolife Sweden AB · Feb 2009